With the common goal of improving drug delivery into the brain, the same glioblastoma cell line and MDCK cells transfected with BCRP (MDCK-BCRP) were appropriately used to study the inhibitory effect of elacridar on P-gp and BCRP at the BBB level [29]. Here, PGP is linked to glioblastoma.